Mechanism of action: Ibuprofen balliculeVisual mnemonic: Ibuprofen mascot “I be pro-Moat in Ad-Ville” “The N said... NSAID”
What it isNonselective COX-1 and COX-2 inhibitor; pain, fever and inflammation.
Why this oneShort action and pediatric liquid formulations make it the flexible OTC NSAID for fever and brief pain.
What limits itGI bleeding, kidney injury and cardiovascular risk rise with exposure. Taken before aspirin it can blunt platelet effect; lithium also rises.
Molecular structure: Ibuprofen
Ibuprofen prescription history
Animated chart of estimated U.S. prescriptions per year, NSAIDs (1914–2026). Ibuprofen enters in 1974 (estimated).
BOXED WARNING NSAID: serious CV thrombotic events (MI, stroke), may occur early and rise with duration; contraindicated in CABG setting; serious GI bleeding, ulceration, perforation (elderly at greater risk).
FDA dosing
Population
Start
Target
Max
Rheumatoid arthritis / osteoarthritis (signs and symptoms, incl. flares)
Adults
400 mg, 600 mg, or 800 mg TID or QID (1,200–3,200 mg/day)
Lowest dose giving acceptable control; RA usually needs higher doses than OA
3200 mg/day
Mild to moderate pain
Adults
400 mg q4–6h PRN
3200 mg/day (doses >400 mg no more effective)
Primary dysmenorrhea
Adults
400 mg q4h PRN, from earliest onset of pain
3200 mg/day
Renal Advanced renal disease: not recommended (no data); if started, monitor renal function closely
Hepatic No dose adjustment labeled; discontinue if liver disease signs/systemic manifestations develop or abnormal LFTs persist/worsen
Chronic arthritis: response sometimes in a few days to a week, most often by two weeks; then review/adjust dose. 3,200 mg/day only if added benefit offsets risk. Pediatric safety/effectiveness not established. Elderly (≥65 yr): use caution.
Instructions
Take with meals or milk if GI complaints occur
Use lowest effective dose for shortest duration
Available strengths
tab 200, 400, 600, 800 mg (200 OTC)
Contraindications
Asthma, urticaria, or allergic-type reactions after aspirin or other NSAIDs
Coronary artery bypass graft (CABG) surgery setting
Cautions
Cardiovascular thrombotic events (incl. post-MI)
Hypertension
Heart failure and edema
GI ulceration, bleeding, perforation
Renal effects; advanced renal disease not recommended
Anaphylactoid reactions (aspirin triad)
Serious skin reactions (SJS/TEN, fixed drug eruption)
DRESS
Fetal toxicity (ductus closure, oligohydramnios)
Not a corticosteroid substitute; may mask fever/inflammation
Hepatic effects (LFT elevations, rare severe hepatic reactions)
Hematologic effects (anemia, platelet inhibition)
Preexisting asthma (aspirin-sensitive)
Ophthalmologic effects (blurred vision, scotomata, color vision change)
Pregnancy Avoid at ~30 weeks gestation and later (premature ductus closure); limit dose/duration at ~20–30 weeks (oligohydramnios/neonatal renal impairment; consider ultrasound if >48 h).
Lactation Unknown whether excreted in human milk; decide whether to discontinue nursing or the drug.